Is clinical research right for you?
In clinical research, patients with specific conditions volunteer to try a new medication or medical device that is evaluated for effectiveness of treating their disease. These medications and devices are studied by scientists and healthcare specialists, as well as an institutional review board (IRB) to ensure the study is safe and ethical for patients.
At AOCC, we are growing our research department and actively enrolling our patients in studies.
Take a look at our current clinical research studies:
RESET-RA: A medical device that is surgically placed to help manage moderate-severed RA. Click here to learn more: SetPoint RESET-RA Study | Vagus Nerve Stimulation for Rheumatoid Arthritis
Enlight LN: This study is for patients that are newly diagnosed with Lupus Nephritis.
COVID-19 Vaccine Study: This study evaluates the response of our patients to the COVID-19 vaccines.
COREVITAS Registry: This is part of an international registry of patients with rheumatic and autoimmune diseases that collects data and studies important correlates.
Novartis NEPTUNUS-1: A new investigational biologic for the treatment of active Sjogren’s syndrome. Click here to learn more: Two-arm Study to Access Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren’s Syndrome
Novartis AIN457: A trial investigating the use of Secukinumab in patients with a unilateral rotator cuff tendinopathy. Click here to learn more: Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy
PRIMA: A blood test that will be used to determine how a patient with RA may respond to various biologics groups.
If you would like to learn more about enrolling in these trials, please call Audrey Droppelman at 704-631-3342 ext. 1170. You may also speak to your rheumatologist.